Research Article
The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension
Table 5
Comparison of disease characteristics between groups with HHD complicated with PH (means ± SD).
| Variables | Q1 | Q2 | Q3 | Univariate analysis | F value | value |
| N | 24 | 23 | 25 | | | Age (years) | 53.6 ± 12.9 | 44.5 ± 12.7 | 44.3 ± 12.9 | 4.096 | 0.21 | BMI | 22.2 ± 3.4 | 22.5 ± 2.3 | 22.1 ± 2.9 | 0.098 | 0.906 | FT3 (pmol/l) | 16.9 ± 7.9 | 22.6 ± 8.5 | 27.3 ± 13.7 | 5.889 | 0.004 | FT4 (pmol/l) | 55.5 ± 23.5 | 68.7 ± 24.7 | 81.5 ± 47.1 | 4.663 | 0.015 | TSH (mIU/l) | 0.0087 ± 0.014 | 0.0056 ± 0.0029 | 0.008 ± 0.008 | 0.653 | 0.523 | TPOAb (IU/ml) | 631.2 ± 568.4 | 1031.6 ± 438.7 | 899.5 ± 427.5 | 4.228 | 0.019 | TGAb (IU/ml) | 193.7 ± 194.7 | 314.2 ± 285.8 | 448.1 ± 792.8 | 1.542 | 0.221 | PASP (mmHg) | 37.2 ± 7.4 | 40.7 ± 9.8 | 44.6 ± 9.9 | 4.027 | 0.022 | LVEF (%) | 58.6 ± 8.6 | 57.6 ± 9.8 | 60.9 ± 3.9 | 1.113 | 0.335 | LA (cm) | 4.03 ± 0.62 | 4.31 ± 0.58 | 3.95 ± 0.58 | 2.403 | 0.098 | RV (cm) | 2.14 ± 0.24 | 2.33 ± 0.32 | 2.23 ± 0.31 | 2.656 | 0.77 | LV (cm) | 4.84 ± 0.43 | 5.10 ± 0.80 | 5.03 ± 0.51 | 1.277 | 0.285 | RA (cm) | 4.51 ± 0.75 | 4.77 ± 1.03 | 4.58 ± 0.96 | 0.498 | 0.610 | Vmax (cm/s) | 274.6 ± 27.3 | 297.4 ± 42.3 | 305.9 ± 44.1 | 4.253 | 0.018 | PGmax (mmHg) | 30.5 ± 6.3 | 36.0 ± 10.5 | 38.2 ± 10.7 | 4.372 | 0.016 |
|
|
Q1: <11.596; Q2: 11.596–40.000; Q3: ≥40.000 IU/l; Q1, Q2, and Q3 were divided on the basis of the tertiles of the serum TRAb level.
|